PSMA PET: FDA Approved and Coming to a Hospital Near You
ACNM/SNMMI Joint Webinar
Gary Ulaner, MD, PhD, FACNM; Katherine Zukotynski, BASc, MD, PhD, P.Eng; Twyla Bartel, DO, MBA, FACNM, FSNMMI
Ashwin Parihar, MBBS, MD
Steven Rowe, MD, PhD
PSMA PET imaging with two radioisotopes has been recently FDA-approved and is rapidly moving into nuclear medicine clinics across the country. This webinar will review the basic mechanism of PSMA-targeted imaging and then spend the majority of the time on the clinical applications and interpretation of PSMA-targeted imaging. The target audience will be nuclear medicine physicians and radiologists. The course would provide expertise in the proper application and interpretation of PSMA-targeted imaging for webinar attendees. The expected outcomes are that attendees will better understand PSMA-targeted imaging and will be able to apply it more appropriately and effectively in their clinics.
1. Discuss the mechanisms of PSMA-targeted imaging
2. Discuss appropriate clinical indications for PSMA-targeted imaging
3. Improve interpretation of PSMA-targeted imaging
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.